Will Ditcham

Will Ditcham is an Adjunct Senior Lecturer at the School of Human Sciences, The University of Western Australia (UWA), and affiliated with the UWA Medical School and the Institute for Paediatric Perioperative Excellence. His research focuses on respiratory infections, antimicrobial therapies, and inhalation drug delivery systems, contributing to UN Sustainable Development Goals related to health and well-being.

Research interests include Pseudomonas aeruginosa biofilm infections, clinical biomarkers for chronic lung conditions, and novel treatments like inhaled ethanol and phage therapies. His work spans pediatric respiratory care, critical care medicine, and translational pharmacology.

Recent articles highlight advancements in nebulizer technology for pediatric tracheostomy patients and biomarker discovery for pulmonary biofilms. His studies on inhaled ethanol’s safety and efficacy in respiratory infections demonstrate a focus on drug delivery innovation.

• Grants & Projects:
• Pre-clinical model for biofilm-induced respiratory disease therapy (2018–2022)
• Particle size efficacy in adolescent asthma inhalers (2014)
• Lung deposition analysis of salbutamol delivery methods (2012)

Labs/teams include collaborations with the Institute for Paediatric Perioperative Excellence and interdisciplinary teams addressing antimicrobial resistance and respiratory drug delivery.